Fig. 2.
(A) Number of drugs in each therapeutic class with clinical or preclinical evidence of activity against SARS-CoV-2. (B) Distribution of drugs currently studied against COVID-19 according to the type of study
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.